Archives of Aesthetic Plastic Surgery

Search

Close

Original Article
Arch Aesthetic Plast Surg. 2011;17(3):159-164. Published online October 1, 2011.
Clinical Use & Problems of ALSA(R) Gel Filler.
Seok Kwun Kim, Chung Min Yoon, Keun Cheol Lee, Su Sung Park
Department of Plastic & Reconstructive Surgery, Dong-A University College of Medicine, Busan, Korea. sgkim1@dau.ac.kr
Abstract
As increasing demands for facial soft tissue augmentation by injection or minimal invasive procedures, filler injection has become a popular and proper method for patients' demands. Autologous substance filler is safe and has no side effects, proceeded with the patient's own blood plasma. From December 2009 to March 2010, subjects were total of 52 patients. Chief complaints of wrinkle on facial parts were extensive. Most patients received multiple injections on several facial parts. Blood samples taken from the patients were put in a centrifuge to separate plasma. Seprerated plasma was heated in 100degrees C with ALSA(R)(Alamouti and Sattler) system. ALSA(R) gel filler was injected in the patients' wrinkles and depressed areas. A week after the ALSA(R) gel filler injection, most of them were satisfied. A month later, satisfaction was relatively high. But after 3 months, inquiry results changed, the number of unsatisfied patients increased. Because of absorption of injected ALSA(R) gel filler. ALSA(R) had less side effects than other fillers. ALSA(R) could be used continuously, because its component was patient's own blood plasma. However, compare to other fillers, duration was relatively short. More research needs to be performed to increase the duration period and supplement the shortcomings.

Keywords :Subcutaneous injection;Plasma;Rejuvenation

Go to Top